Study | Year | Patient (Hips) | Mean Age(y) | Mean FollowUp (yrs) | Implantation Type | Preoperative LLD(mm) | Postoperative LLD(mm) | Preoperative Function | Postoperative Function | Revision | Complication | Survival |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lee et al. | 2017 | 68 (68) | 48(16–73) | 8.5(5.2–10) | Monobloc Cementless[Corail, DePuy] | NA | 2.2(−2–14) | NA | HHS: 91 (73–100) UCLA activity: 5.5 (3–8) | None | Sciatic nerve palsy: 1 Ectopic ossification: 9 | 100% |
Huang et al. | 2016 | 33(33) | 46.8 (24–72) | 4.5 (2.2–11.3) | Various: Monobloc cementless: 22 Modular Femoral Component[SROM, DePuy]: 11 | NA | NA | HHS: 37.6 (15–56) | HHS: 92.8(70–100) Diminished or no limping: 45% (15/33) dissatisfied: 9.1%(3/33) | None | Ectopic ossification: 2 Sciatic nerve palsy: 1 Intraoperative fracture: 4 | NA |
Lee et al. | 2016 | 37(41) | 43.8 ± 12.7 (18.9–66.3) | 10.4 ± 3.3 (5.2–16.0) | Aluminae-alumina Cementless | 20 ± 12 | 2 ± 9 | HHS:66.7 ± 17.4 | HHS: 96.8 ± 6.8 Lengthening: 17 ± 9 Diminished or no limping: 97% (36/37) | None | Intraoperative fracture: 14 Peroneal nerve palsy: 1 Deep vein thrombosis: 1 | NA |
Seufert et al. | 2015 | 28(35) | 51.6 (22–74) | 8.2 (2–14) | Modular Femoral Component[SROM, DePuy] | 18.6 | 7 | HHS: 49.8 ± 9.2 | HHS: 93.9 ± 8.5 Diminished or no limping: 94.3% (33/35) | Deep Infection: 1 | Ectopic ossification: 2 Dislocation: 1 | NA |
Lim et al. | 2014 | 23(23) | 49.2 (25–69) | 3.5 (2–7) | Monobloc Cementless: Bencox II 22,Accolade 1 | 15 (7–25) | 3 (1–7) | HHS: 48.3 (42–67) | HHS: 92.4 (79–97) | Sciatic nerve palsy: 1 | Sciatic nerve palsy: 1 Intraoperative fracture: 3 | 96% |
Al-Khateeb et al. | 2014 | 14(15) | 32.8 (23–55) | 10.1 (5–15) | Custom-made Cementless | NA | NA | HHS: 41(27–57) Trendelenburg sign(+): 11(78%) Walking aids: 8 | HHS: 80(51–94) Trendelenburg sign(+): 3(21%) Walking aids: 1 | Aseptic loosening: 3 Deep infection: 1 | Ectopic ossification: 1 Dislocation: 1 | Femoral stem: 100% Acetabular components: 79% |
Baghdadi et al. | 2013 | 95(99) | 48 ± 15 | 8 ± 5 | Cementless implants: 76 Hybrid implants:21 | NA | NA | HHS: 56 (25–85) | HHS: 88 (50–100) | Aseptic loose stem component: 5 Liner wear: 3 Aseptic loose cup component: 1 Deep infection: 1 | Intraoperative fracture: 8 (femoral), 1 (acetabular) Sciatic nerve palsy: 3 Thromboembolic: 1 Infection: 1 Dislocation: 1 Adductor tenotomy: 1 | Cementless implants:90% (76%–96%) Hybrid implants:86% (57%–96%) |
Traina et al. | 2011 | 27(32) | 37.8(19–65) | 12.3(5–21) | Cement-less: 31 Cemented:1 | NA | 9(0–26) | HHS: 50.1(25–75) | HHS: 87.5 (73–96) Average Lengthening: 12 (6–27) | Failure for cemented component: 1 | Sciatic nerve palsy: 2 Intraoperative fracture: 1 Hematoma: 1 | 96.9%(90.8% -100.0%) |
Pietrzak et al. | 2011 | 9(9) | 56(41–69) | 15(11–21) | Cement-less: 6 Cemented:3 | NA | NA | HHS: 34 WOMAC: 77 | HHS: 93 WOMAC: 6 | None | NA | 100% |
Current study | 2017 | 71(88) | 49.94 ± 11.40(36–73) | 10.09 ± 1.84(7.7–14) | Monobloc cementless: 88 | 24.3 ± 7.8(8–36) | 2.4 ± 2.8(−2–10) | HHS: 46.42 ± 6.11, Sym: 11.37 ± 2.40, Pain:19.39 ± 5.90, DL: 34.80 ± 3.78, SARA: 8.07 ± 1.77, QOF: 6.62 ± 1.21, PCS: 15.80 ± 2.69, MCS: 16.63 ± 2.80 | HHS: 89.70 ± 5.46, Sym: 17.19 ± 1.45, Pain:37.32 ± 2.05, DL: 65.77 ± 1.17, SARA: 14.55 ± 1.96, QOF: 13.42 ± 1.31, PCS: 23.11 ± 2.78, MCS: 24.55 ± 3.13 | Fracture: 1 | Intraoperativel fracture: 2 Sciatic nerve palsy:2 Heterotopic ossification: 2 Dislocation: 1 Thigh pain: 1 | 98.3%(94.9%–99.9%) |